BioLife Solutions, Inc. (BLFS)
NASDAQ: BLFS · Real-Time Price · USD
20.99
-1.80 (-7.90%)
Apr 10, 2025, 4:00 PM EDT - Market closed
BioLife Solutions Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for BioLife Solutions stock have an average target of 30.57, with a low estimate of 27 and a high estimate of 33. The average target predicts an increase of 45.64% from the current stock price of 20.99.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 6, 2025.
Analyst Ratings
The average analyst rating for BioLife Solutions stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
---|---|---|---|---|---|---|
Strong Buy | 5 | 5 | 5 | 5 | 6 | 5 |
Buy | 1 | 2 | 2 | 2 | 2 | 2 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 6 | 7 | 7 | 7 | 8 | 7 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $27 → $30 | Strong Buy | Maintains | $27 → $30 | +42.93% | Mar 6, 2025 |
Northland Capital Markets | Northland Capital Markets | Buy Maintains $28 → $31 | Buy | Maintains | $28 → $31 | +47.69% | Jan 8, 2025 |
Benchmark | Benchmark | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +42.93% | Dec 19, 2024 |
Keybanc | Keybanc | Buy Maintains $30 → $33 | Buy | Maintains | $30 → $33 | +57.22% | Dec 13, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $29 → $27 | Strong Buy | Maintains | $29 → $27 | +28.63% | Nov 18, 2024 |
Financial Forecast
Revenue This Year
99.06M
from 82.25M
Increased by 20.43%
Revenue Next Year
118.06M
from 99.06M
Increased by 19.18%
EPS This Year
-0.12
from -0.44
EPS Next Year
0.12
from -0.12
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 102.9M | 127.7M | 149.2M | ||
Avg | 99.1M | 118.1M | 145.0M | ||
Low | 93.6M | 109.8M | 139.3M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 25.1% | 28.9% | 26.4% | ||
Avg | 20.4% | 19.2% | 22.8% | ||
Low | 13.8% | 10.8% | 18.0% |
EPS Forecast
EPS | 2025 | 2026 | 2027 |
---|---|---|---|
High | -0.08 | 0.16 | 0.55 |
Avg | -0.12 | 0.12 | 0.53 |
Low | -0.16 | 0.09 | 0.51 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | - | - | 346.1% |
Avg | - | - | 333.3% |
Low | - | - | 316.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.